Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "NFI"

1513 News Found

Trialt and Viedoc team up to transform clinical trials
Clinical Trials | April 08, 2026

Trialt and Viedoc team up to transform clinical trials

The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide


Transgene and NEC join forces to advance personalized cancer vaccine
R&D | April 08, 2026

Transgene and NEC join forces to advance personalized cancer vaccine

TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor


OneCyte and Kemp Proteins to revolutionize cell line development
Biopharma | April 08, 2026

OneCyte and Kemp Proteins to revolutionize cell line development

Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules


Allergan Aesthetics opens cutting-edge AMI training center in Austin
News | April 08, 2026

Allergan Aesthetics opens cutting-edge AMI training center in Austin

The center combines rigorous scientific instruction with practical, hands-on training, equipping providers with the clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered care


EU nod to Rezurock for chronic GVHD in adults & teens
News | April 08, 2026

EU nod to Rezurock for chronic GVHD in adults & teens

Chronic GVHD is a serious and potentially life-threatening condition, imposing profound physical and emotional burdens on a substantial proportion of patients following allogeneic stem cell transplantation


Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer
News | April 07, 2026

Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer

Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies


Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
Biopharma | April 07, 2026

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline


Apollo report warns India’s silent health risks are striking earlier among young adults
Hospitals | April 07, 2026

Apollo report warns India’s silent health risks are striking earlier among young adults

Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals